| Pharmaceutical Information |
| Drug Name |
Cloxacillin |
| Drug ID |
BADD_D00510 |
| Description |
A semi-synthetic penicillin antibiotic which is a chlorinated derivative of [oxacillin]. |
| Indications and Usage |
Used to treat infections caused by penicillinase-producing staphylococci, including pneumococci, group A beta-hemolytic streptococci, and penicillin G-sensitive and penicillin G-resistant staphylococci. |
| Marketing Status |
Discontinued |
| ATC Code |
J01CF02 |
| DrugBank ID |
DB01147
|
| KEGG ID |
D07733
|
| MeSH ID |
D003023
|
| PubChem ID |
6098
|
| TTD Drug ID |
D04KTZ
|
| NDC Product Code |
Not Available |
| Synonyms |
Cloxacillin | Chloroxacillin | Syntarpen | Tegopen | Cloxacillin Sodium | Sodium, Cloxacillin | Sodium Cloxacillin | Cloxacillin, Sodium |
|
| Chemical Information |
| Molecular Formula |
C19H18ClN3O5S |
| CAS Registry Number |
61-72-3 |
| SMILES |
CC1=C(C(=NO1)C2=CC=CC=C2Cl)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
